# Nutritional Supplementation of Flavonoids Quercetin and Curcumin for Early Mild Symptoms of COVID-19

> **NCT05130671** · NA · COMPLETED · sponsor: **King Edward Medical University** · enrollment: 50 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Standard of care
- **DIETARY_SUPPLEMENT:** Investigational treatment

## Key facts

- **NCT ID:** NCT05130671
- **Lead sponsor:** King Edward Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-25
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05130671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05130671, "Nutritional Supplementation of Flavonoids Quercetin and Curcumin for Early Mild Symptoms of COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05130671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*